July 12, 2014 9:01 PM ET


Company Overview of Forward Pharma A/S

Company Overview

Forward Pharma A/S, a biotechnology company, develops immunomodulatory compounds for the treatment of psoriasis, and other autoimmune and inflammatory disorders. Its FP 187 is an oral small molecule. The company was founded in 2005 and is headquartered in Copenhagen, Denmark with a subsidiary operation in Leipzig, Germany.

Nyhavn 43B

Copenhagen K

Copenhagen,  1051


Founded in 2005


45 33 44 42 42


45 33 44 42 44

Key Executives for Forward Pharma A/S

Chief Executive Officer
Chief Operating Officer and Director
Compensation as of Fiscal Year 2014.

Forward Pharma A/S Key Developments

Forward Pharma A/S Presents at BioEquity Europe 2013, May-23-2013 02:30 PM

Forward Pharma A/S Presents at BioEquity Europe 2013, May-23-2013 02:30 PM. Venue: Sheraton Stockholm, Stockholm, Sweden.

Similar Private Companies By Industry

Company Name Region
Accip Biotech A/S Europe
Egalet a/s Europe
Nemo-Med A/S Europe
Bioneer A/S Europe
PentaBase ApS Europe

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Forward Pharma A/S, please visit www.forward-pharma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.